--- title: "The oil and petrochemical sector rose at the beginning of the trading session, and MPCSH hit the daily limit" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/245607196.md" description: "The oil and petrochemical sector rose at the beginning of the trading session, with MPCSH hitting the limit up, followed by gains in Keli Co., Tongyuan Petroleum, Xinjin Power, Lanyan Holdings, Zhunyou Co., and Taishan Petroleum" datetime: "2025-06-23T01:34:13.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/245607196.md) - [en](https://longbridge.com/en/news/245607196.md) - [zh-HK](https://longbridge.com/zh-HK/news/245607196.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/245607196.md) | [English](https://longbridge.com/en/news/245607196.md) # The oil and petrochemical sector rose at the beginning of the trading session, and MPCSH hit the daily limit The oil and petrochemical sector rose at the beginning of the trading session, with MPCSH hitting the daily limit, followed by gains in Keli Co., Tongyuan Petroleum, Xinjin Power, Lanyan Holdings, Zhunyou Co., and Taishan Petroleum ### 相關股票 - [MPCSH (000637.CN)](https://longbridge.com/zh-HK/quote/000637.CN.md) - [NEW JCM (300157.CN)](https://longbridge.com/zh-HK/quote/300157.CN.md) - [Blue Flame Holding (000968.CN)](https://longbridge.com/zh-HK/quote/000968.CN.md) - [XZPT (002207.CN)](https://longbridge.com/zh-HK/quote/002207.CN.md) - [TSPC (000554.CN)](https://longbridge.com/zh-HK/quote/000554.CN.md) - [Tong Petrotech (300164.CN)](https://longbridge.com/zh-HK/quote/300164.CN.md) ## 相關資訊與研究 - [BYD reportedly explores F1 entry to boost global brand appeal](https://longbridge.com/zh-HK/news/278576491.md) - [Bessent, on safe passage of ships in Strait of Hormuz, says U.S. is on track to get this solved](https://longbridge.com/zh-HK/news/278171367.md) - [Junshi Biosciences’ Subcutaneous Toripalimab NDAs Accepted in China](https://longbridge.com/zh-HK/news/278445287.md) - [13:46 ETNanchang Optoelectronic Industry Cluster brilla en ISLE 2026](https://longbridge.com/zh-HK/news/278597263.md) - [Kainova Therapeutics reports positive phase 1 results for DT‑9081 in advanced solid tumours](https://longbridge.com/zh-HK/news/278526333.md)